Purpose:
Cervical cancer (CC), one of the common cancers in women worldwide, is a leading cause of cancer-related death in developing countries. Elucidation of the molecular mechanisms involved in the pathogenesis of CC are fundamental to an understanding of the occurrence and development of CC. In spite of great improvements achieved in the surgical interventions and chemoradiotherapy of CC, the prognosis for CC is still very poor. erapeutic strategies for this disease have not changed dramatically for many years, and are mostly based on a limited understanding of the biology of CC. Although a number of genetic and molecular changes have been found to correlate with the progression of CC, an in-depth understanding of the molecular markers would be helpful to identify the targets for the treatment of CC.
p27 and phosphatase and tensin homolog (PTEN) are the biomolecular prognostic factors for cervical cancer and have negative correlation with the depth of stromal invasion, tumor size clinical stage and survival [1, 2] . Small non-coding RNAs (microRNAs; miRs) are a class of endogenous noncoding, highly conserved RNAs with about 22 nucleotides in length that are encoded in plant and animal genomes. MiRNAs have been found to be involved in the pathogenesis of most cancers [3] . ey can down-regulate mRNA expression by repressing translation or by directly cleaving the targeted mRNA. In recent years, our understanding of miRNA has expanded from the initially identi ed functions in the development of round worms to highly expressed and ubiquitous regulators implicated in a wide array of critical processes, including proliferation, cell death, di erentiation, metabolism and, importantly, tumorigenesis. Over-expressed miRNAs may act as oncogenes to down-regulate tumor suppressor genes and/or genes controlling cell di erentiation and apoptosis, whereas the down-regulated miRNAs act as tumor suppressor genes to negatively regulate oncogenes and/or genes controlling cell di erentiation and apoptosis [4, 5] . MiR-222 is composed of two highly homologous miRNAs, whose up-regulation has been recently described in several types of human cancers. MiR-222 has been considered to act as oncogenes or tumor suppressors, depending on the tumor microenvironment [6] . PCR technology has been used to investigate the expression of miRNAs in CC and adjacent normal tissues. is study was undertaken to investigate the role of miR-222 in CC. Our results may provide a new target for the treatment of CC.
Materials and Methods

Sample collection
Specimens (n = 38) were obtained from patients in the Shanghai Tenth People's Hospital, Tongji University Medical College, from 2004 to 2012. Of the 38 specimens, 19 were CC and 19 were adjacent normal tissues from the same patients (NC). Samples were immediately placed in liquid nitrogen and stored at -80 o C for use.
Information on one patient was unavailable, so samples from only 18 patients were studied. e median age was 46.77 years (range: 36-61 years). ere are 12 (67%) patients who were in the stage I of cancer, while 6 (33%) cases were in the stages II-IV. Among these specimens, 10 (56%) were positive for HPV and 8 (44%) negative for HPV, including 5 (28%) specimens with the invasion depth of less than 5 mm and the rest 13 (72%) with the invasion depth of deeper than 5 mm. In 8 (44%) patients, the tumor size was smaller than 5 cm 2 . Moreover, 67% of patients were diagnosed as CC at stage I and 23% with CC in stage II-IV. Eight (44%) patients received chemotherapy and 10 (56%) had had no chemotherapy at the start of the study (Table 1) .
Informed consent was obtained from each patient and the study was approved by the ethics committee of our hospital before the start of the study.
Cell lines and transfections
Human cervical cancer cell line HeLa cells and SiHa cells were grown in Dulbecco's modi ed Eagle's medium containing 10% fetal bovine serum (FBS), glutamine, and ampicillin/ streptomycin in a 5% CO2. For transfection assay, HeLa cells s. e threshold cycle is de ned as the cycle number at which the uorescence passes the xed threshold. For quanti cation, the 2 (-∆ct) method was used as previously described [7] Experiments were carried out in triplicate at each time point.
Western blot assay
e cells were washed in ice-cold PBS, and subsequently lysed in ice-cold NP40 lysis bu er (0.5% NP40, 50 mM HEPES [pH=7], 250 mM NaCl, 5 mM EDTA, 50 mM NaF, 0.5 mM Na3VO4, 0.5 mM phenylmethylsulfonyl uoride, complete inhibitor; Roche, Basel, Switzerland). Proteins were subjected to polyacrylamide gel electrophoresis, transferred onto nitrocellulose membranes (Bio-Rad), incubated with speci c primary antibodies, and visualized using enhanced chemiluminescence kit (Central Laboratory of the Shanghai Tenth People's Hospital, China). For immunoblotting, membranes were blocked for 1 h with 5% non-fat dry milk in tris-bu ered saline containing 0.1% Tween-20, and incubated at 4 o C over night with primary antibody. Detection was performed by peroxidase-conjugated secondary antibodies using the enhanced chemiluminescence kit (Shanghai Tenth People's Hospital, China). e antibodies used in this work were: anti-p27 (sc-56338, Santa Cruz Biotechnology, Dallas, TX USA), antip21 (#2947s cell signaling Inc) anti-e-cadherin (sc-52327, Santa Cruz Biotechnology), anti-PTEN (sc-9145, Santa Cruz Biotechnology) and anti-paxillin (610051, BD Transduction Laboratories, Chestnut Hill, MA, USA).
Migration assay
Transwells Permeable Supports with 6.5-mm diameter inserts, 8.0 mM pore size, and polycarbonate membrane (Corning Incorporate, Corning, NY, USA) were used to perform migration assay. HeLa cells and SiHa cells were grown as indicated above, and harvested by TrypLE Express (Invitrogen). en, 10 5 cells were washed three times and re-suspended in 1% FBS containing Dulbecco's modi ed Eagle's medium and seeded in the upper chamber. e lower chamber was lled with 500 ml of culture medium containing 10% FBS and 5 mg/mlbronectin. Cells were incubated at 37ºC for 24 h. e transwells were then removed from the 24-well plates and stained with 0.1% crystal violet in 25% methanol. Non-migrated cells were removed from the top of transwell with a cotton swab.
e percentage of migrated cells was determined by eluting crystal violet in 1% SDS. Representative images were captured under a microscope.
Flow cytometry
For cell cycle detection, 1×10 6 cells were collected and xed in 70% ice-cold ethanol at 4ºC overnight. Before staining, all samples were washed twice with PBS, treated with 1 mg/ml ribonuclease A and stained with 20 μg/ml propidium iodide (Sigma-Aldrich, St. Louis, MO, USA), followed by ow cytometry (FACScan). For apoptosis analysis, cells were harvested and stained in duplicate with Allophycocyanin-annexin V and propidium iodide (Sigma-Aldrich) according to the manufacturer's instructions. e percent of apoptotic cells was determined as the apoptosis index (AI). Each experiment was performed in triplicate.
Immuno uorescence microscopy
Cells were grown on coverslips and xed in 4% paraformaldehyde, permeabilized in 0.1% Triton X-100 and blocked in 1% BSA. Primary anti-bodies were used at 1:1000 in blocking bu er. A er incubation for 1-24 h at room temperature (depending on the antibodies), cells were washed in blocking bu er and then incubated with secondary antibody at 1:500 in blocking bu er (plus uorescently-labeled phalloidin if required) for 1 h. Coverslips were washed and then mounted on 
Statistical analysis
All of the experiments were performed for three times. Continuous variables were expressed as means ± standard deviation. One-tailed Student's t-test was used for comparisons. A value of P<0.05 was considered statistically signi cant. Data were expressed as means from experiments performed in triplicate. Statistical analysis of the tissues samples was performed using the Mann-Whitney test to evaluate the signi cance of di erences between groups.
Results
MiR-222 expression in CC
To evaluate the miR-222 expression in vi o, the miR-222 expression was detected in CC tissues and adjacent normal tissues. uantitative RT-PCR showed a 2.48-fold increase in miR-222 expression in CC as compared with that in adjacent normal tissues (P<0.01; Figure1A). In addition, the miR-222 expression increased as the invasion depth (median, 1.22 and 2.97, P <0.05, Mann-Whitney) and the tumor volume (median, 1.21 and 3.11, P <0.05, Mann-Whitney) increased (Figure 1B and C) . miR-222 expression was not associated with chemotherapy ( Figure 1D ), stage of CC ( Figure 1E ) or HPV infection ( Figure 1F ).
TargetScan analysis showed that p27 and PTEN were the targets of miR-222, but the clinicopathological ndings did not demonstrate a relationship between miR-222 and p27 or PTEN in CC. To further investigate the association of miR-222 with p27 and PTEN, the expression levels of p27 and PTEN were determined in 10 pairs of samples by RT-PCR. Spearman's correction analysis showed signi cantly negative correlation between p27 and miR-222, as well as between PTEN and miR-222 (R=-0.556, P=0.038; R=-0.552, P=0.049, respectively, Figure 2 B,C).
Impact of miR-222 over-expression in HeLa cells and SiHa cells
MiR-222 promotes the growth of HeLa cells and SiHa cells
To test whether miR-222 functions as an oncogene, the e ect of miR-222 on CC cell proliferation was investigated. Firstly, the increase in miR-222 expression was determined in transfected HeLa and SiHa cells using RT-PCR ( Figure-2A ) (256-and 512-fold increase, respectively). At 48 h post-transfection, the e ect of miR-222 over-expression on cell proliferation was evaluated by MTT assay and colony-formation test. MiR-222 signi cantly increased the proliferation of CC cells when compared with control group ( Figure 3A and C, Figure-3B and D, Figure 3E ). Moreover, the protein expression of p27 was also measured in HeLa and SiHa cells at 48 h a er transfection with miR-222 and compared with the control group. Overexpression of miR-222 resulted in the down-regulation of p27 expression ( Figure 3F 
MiR-222 elevates the number of HeLa cells and SiHa cells in S phase
A er transfection with miR-222 in HeLa cells, the cell cycle was examined by ow cytometry. Results showed the number of HeLa and SiHa cells in S phase increased when compared with control group ( Figure 4A , Figure 4B , Figure 4D ). ere was no signi cant di erence in apoptosis between the miR-222 transfection group and the control group in either cell line. e up-regulation of miR-222 in HeLa cells did not induce an increase in cell apoptosis, suggesting miR-222 may not a ect the apoptosis of HeLa cells ( Figure 4C ). Similar ndings were observed in SiHa cells (data not shown).
MiR-222 enhances the migration and in asion of HeLa and SiHa cells
Previous work has shown that miR-222 may increase the invasiveness of some cancers, such as hepatocarcinoma, glioma and gastric cancer [8] . To demonstrate the role of miR-222 in the migration of HeLa cells, the scratch wound healing assay was performed to investigate the in uence of miR-222 overexpression on the migration of HeLa and SiHa cells. At 48 h a er transfection, the wound width in the treated group was smaller than that in control group ( Figure 5 -A, Figure 5 -B). To further demonstrate the e ects of miR-222 on the invasion of HeLa and SiHa cells, the Transwell invasion assay was done. Similar ndings were acquired ( Figure 5C , Figure 5D ). Furthermore, over-expression of miR-222 in HeLa cells and SiHa cells reduced the CDH1 and PTEN expression with an increase in Paxillin expression in HeLa cells and MMP1 expression in SiHa cells: two proteins related to the invasion ability (8) (Figure 6, Figure 7) . e above ndings demonstrate that the transfection of miR-222 increases the invasion of HeLa and SiHa cells, suggesting the elevated invasion of CC.
Discussion
Studies have been undertaken to investigate the correlation between several human cancers and expression of miRNAs [3] . It has been found that the locations of miRNAs in the genome seem to be non-random, and a signi cant number of miRNA are located at the fragile sites (unstable regions that have been shown to promote DNA instability in cancer cells) or genomic regions linked to cancer [9] . Deregulation (e.g., over-expression or loss of expression) of these "cancerous" miRNAs contributes to the occurrence and progression of cancers by favoring uncontrolled proliferation and promoting invasive behaviors, and by regulating apoptosis [10, 11] . Another major issue in clinics is clearly represented by the need of biomarkers for an early diagnosis, extremely important considering that the survival and prognosis of patients depend on the stage of cancer at the time of diagnosis: diagnosis of cancers at early stage is usually associated with a better prognosis. MiRNAs have a great potential as novel biomarkers for the early diagnosis of cancers [12] . It has been shown that miR-222 is over-expressed in a majority of epithelium derived cancers [13] , but plays a tumor-suppressive role in erythroleukemic cells by inhibiting erythropoiesis through down-regulating c-Kit receptor. Galardi et al. identi ed the cell cycle regulator, p27 Kip1 , as a target of miR-222 [14, 15] , which was con rmed in thyroid papillary carcinoma [16] , breast cancer [17] , hepatocellular carcinoma and lung cancer [18] . It is evident that a comprehensive understanding of the functional role of miRNAs in oncogenesis will be achieved only by elucidating their mechanisms of action in each type of tumors. Although there are no reported studies concerning the relationship between miR-222 and CC; however, our study did show a correlation between miR-222 and CC.
In addition to microarray-based studies on the expression pro ling, other methods have been developed for the detection of miRNAs, such as quantitative real-time PCR [19] . In order to investigate the involvement of miR-222 in tumorigenesis of CC, RT-PCR was done to detect the miR-222 expression in normal cervical tissues and in CC. Results showed miR-222 was up-regulated in CC in comparison with normal tissues, suggesting a role of miR-222 in the development of CC. is might also imply that there is dysfunction of miR-222 in the CC, which may be an important factor in the development of CC. MiR-222 over-expression has important consequences in the tumorigenesis of CC and may be considered a marker of increased tumorigenesis.
e cell cycle inhibitor, p27 Kip1 , is a member of the family of tumor suppressors. Recent reports have described it as a target gene of miR-222 [14, 15] . e cell cycle regulatory IDP p27 Kip1 (p27) can switch the activity of cyclin-dependent ki-nases (Cdks) from an inhibited to an activated state through tyrosine phosphorylation (20) . Deregulation of p27 has been implicated as a reliable prognostic indicator of many human malignancies [21] . Mice de cient in p27 exhibit increased susceptibility to tumor progression, and tumorigenecity is accelerated in Rb +/-p27 -/-and p18INK4c -/-p27 -/-mice [22] , suggesting that p27 Kip1 is a rate-limiting factor for tumorigenesis. Lee et al. found the direct evidence related to the e ect of p27 on hTERT expression in both human CC cells and primary MEFs de cient in p27 [23] . In the present study, the HeLa and SiHa cells were independently transfected with miR-222 to interfere with the miR-222 expression. In the control group, transfection of scrambled miR-222 was performed. Results showed that miR-222 over-expression resulted in a phenotypic change in HeLa and SiHa cells that was characterized by more and denser colonies, and down-regulation of miR-222 inhibited the colony formation (data not shown). e cell proliferation assay showed similar results to those from the colony formation assay. In addition, miR-222 increased the number of HeLa and SiHa cells in the S phase and had no in uence on the apoptosis. Moreover, decreased expression of p27 was noted in HeLa and SiHa cells a er miR-222 transfection. e above ndings suggest that miR-222 a ects p27 Kip1 to regulate the proliferation and cell cycle of HeLa cells. MiR-222-induced p27kip1 down-regulation may promote the growth of HeLa cells, but this relationship needs further study. e mechanism(s) by which miR-222 up-regulates the proliferation of HeLa cells will be investigated in future studies.
e cell migration assay showed that HeLa and SiHa cells that were transfected with miR-222 showed increased migration. Comparable results were obtained from the scratch wound healing assay of SiHa and HeLa cells. As miRNAs may a ect the expression of many proteins, our ndings showed that the miR-222 expression in HeLa cells transfected with miR-222 was inversely related to the expression of E-cadherin, PTEN and paxillin. E-cadherin has been demonstrated to directly a ect the migration of cancer cells [24] . Loss of expression of E-cadherin and cadherin 2 may be associated with the loss of epithelial cell polarity and alterations in the intercellular adhesion [25] . It has been reported that miR-221 and 222 may regulate TRAIL resistance and enhance tumorigenecity through down-regulating PTEN and TIMP3 [8] . PTEN has been proposed as a promising biological marker for early diagnosis and prognostic evaluation of CC [1] . Our results showed miR-222 can down-regulate PTEN protein expression, which up-regulates the protein expression of MMP1 and paxillin to promote the migration of CC; therefore, miR-222 expression may be used to predict the aggressive behaviors of CC. e mechanisms by which miR-222 works are under investigation.
In summary, our studies revealed that miR-222 expression is positively related to the progression of CC. Furthermore, miR-222 may function as a tumor promotor through downregulating p27 Kip1 and PTEN in CC. ese ndings suggest that miR-222 may serve as a potential novel target for the clinical therapy of CC.
Challenges
In the present study, only 19 patients were recruited and only 18 sets of samples analysed fully. Future studies with large sample sizes are required to validate our ndings. In addition, the role of miR-222 in CC was investigated in only two CC cell lines, and whether miR-222 a ects the aggressive behavior of other types of CC cell lines (such as Caski cells) is still unknown.
